Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Bidding war ends with Japara recommending aged care takeover at 81% premium

  • In News
  • July 27, 2021
  • Alfred Chan
Bidding war ends with Japara recommending aged care takeover at 81% premium

Despite the struggles endured by aged care operators through the pandemic, business has been booming for most, including Japara Healthcare (ASX: JHC) whose Board of Directors is recommending a $588 million takeover offer from rival Calvary after a spirited bidding war.

The offer for Japara’s 50 homes and five retirement villages that house more than 4,000 residents comes via a takeover offer to acquire 100% of JHC shares at $1.40 each. This represents an 81% premium to the 30-day volume weighted average.

Over that period however, JHC shares have continued to climb to close yesterday at $1.165 for the offer to still be a 20% premium on the previous close. If accepted, the offer implies an equity value of $380 million with an enterprise value of $588 million under the Scheme Implementation Deed.

“The Japara Board is pleased to unanimously recommend this proposal to shareholders. In making this assessment, the Board considered a number of alternatives including a competing proposal and standalone value creation from the execution of our existing strategy,” said Japara Chairman, Linda Bardo.

“After careful consideration of the future opportunities for Japara, along with sector and regulatory uncertainty, and execution risks, the Board has determined that the Scheme delivers compelling value to Japara shareholders”.

A takeover of Japara has been on the cards for several months now with the initial offer from Calvary coming on 30 April, 2021 when offering to purchase all JHC shares at $1.04 each. This offer was then increased to $1.20 per share on 7 June.

Bolton Clarke then entered the fray with an offer of $1.22 per share on 15 June which was recommended by the Japara Board unless a superior offer was received which now comes as the $1.40 per share counter-offer from Calvary.

Unlike the earlier offers however, Japara have now confirmed that a Scheme Consideration meeting will take place in October 2021 whereby shareholders are being unanimously recommended by the Board to vote in favour of the scheme.

Once settled, Calvary would consolidate its position as one of the largest community care operators in Australia which currently operates 14 public and private hospitals as well as 17 retirement and aged care facilities.

Established in 1885 as a charitable Catholic non-for-profit organisation, Calvary’s mission is to provide health care to the most vulnerable, including those reaching the end of their life.

For the Half Year ended 31 December 2021, Japara Healthcare reported $220.3m revenue with $8m EBITDA. Despite all the troubles linked to COVID outbreaks in aged care facilities, the Group still had 89% occupancy across their residencies over the period with $137m cash on hand.

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  •  
  •  
  •  
  •  
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.